Alphatec Spine Announces Stockholder Approval of Share Issuance Related to the Acquisition of Scient'x Groupe SAS
17 Mars 2010 - 2:15PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures and markets products for the surgical
treatment of spine disorders, with a focus on treating conditions
affecting the aging spine, announced today that at a special
meeting of stockholders held on March 16, 2010, its stockholders
approved the issuance of 24,000,000 shares of the Company's common
stock in connection with the acquisition of Scient'x Groupe SAS.
Approximately 78% of the shares of the Company's common stock that
were eligible to vote on the matter were voted. Of the shares
that were voted, over 99% voted in favor of the transaction. The
Company expects the closing of the transaction to be completed
prior to the end of the first quarter.
"We are pleased that our stockholders have overwhelmingly
supported this transaction, which we believe will create a company
with global scale and presence, as well as a unique and
differentiated product portfolio," stated Dirk Kuyper, the
Company's President and CEO.
The transaction remains subject to customary closing
conditions.
About Scient'x
Scient'x is a medical device company based in France that
designs, develops and manufactures spinal implants and
instrumentation. Scient'x was founded in 1988 and offers today
a full range of implants for spinal fusions, posterior semi-rigid
stabilization and a cervical total disc replacement
device. Its international distribution network consists of a
direct sales force in France and the U.K., a hybrid of direct sales
force and distributors in Italy, as well as exclusive and
non-exclusive distributors in more than 50 countries including the
United States. The Scient'x surgeon education and training network
augments its international distribution capabilities.
Scient'x key products includes the Isobar™ rod product group, a
semi-rigid rod technology used in spinal fusion surgeries, as well
as cervical and lumbar implants, which are used predominantly in
spine fusion surgeries. Outside of the United States, Scient'x
markets a unique and proprietary ceramic-on-ceramic cervical total
disc replacement device, DiscoCerv®, which has been implanted in
over 3,000 patients since its initial launch.
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec
Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device
company that designs, develops, manufactures and markets products
for the surgical treatment of spine disorders, primarily focused on
the aging spine. The Company's mission is to combine
world-class customer service with innovative, surgeon-driven design
that will help improve the aging patient's quality of
life. The Company is poised to achieve its goal through new
solutions for patients with osteoporosis, stenosis and other aging
spine deformities, improved minimally invasive products and
techniques and integrated biologics solutions. In addition to
its US operations, the Company also markets its spine products in
Europe. In Asia, the Company markets a broad line of spine and
orthopedic products through its subsidiary, Alphatec Pacific,
Inc. For more information, please visit
www.alphatecspine.com.
Also visit the Aging Spine Center, www.agingspinecenter.com, a
web-based information portal for healthcare providers and patients
regarding aging spine disorders and their treatment. The
Company is working with the National Osteoporosis Foundation as
well as other clinical portals that provide peer-reviewed content,
to populate the Aging Spine Center. The interactive website
enables patients to review pertinent information about disorders
that affect the aging spine in an easy-to-understand format that
includes videos, graphics and questions that should be asked of
caregivers. Medical information on the website includes published
abstracts regarding the aging spine.
Forward-Looking Statements
This press release contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, as amended,
which are intended to be covered by safe harbors created thereby.
Shareholders are cautioned that all forward-looking statements are
based largely on Alphatec's expectations and involve risks and
uncertainties, some of which cannot be predicted or are beyond
Alphatec's control, including without limitation, the occurrence of
any event, change or other circumstances that could give rise to
the termination of the acquisition agreement; the outcome of any
legal proceedings that have been, or may be, instituted against the
Company or Scient'x related to the acquisition agreement; the
failure to satisfy other conditions to completion of the
transaction. Additional factors that could cause results to differ
materially from those described in the forward-looking statements
can be found in the Company's Annual Report on Form 10-K and in the
Company's other filings with the Securities and Exchange Commission
(the "SEC") available at the SEC's website at
http://www.sec.gov.
The statements in this press release reflect the Company's
expectations and beliefs as of the date of this release. The
Company anticipates that subsequent events and developments will
cause its expectations and beliefs to change. However, while the
Company may elect to update these forward-looking statements
publicly at some point in the future, the Company specifically
disclaims any obligation to do so, whether as a result of new
information, future events or otherwise. These forward-looking
statements should not be relied upon as representing the Company's
views as of any date after the date of this release.
CONTACT: Westwicke Partners
Lynn C. Pieper
(415) 202-5678
lynn.pieper@westwicke.com
Alphatec Spine, Inc.
Peter C. Wulff, Chief Financial Officer
(760) 494-6746
investorrelations@alphatecspine.com
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024